Research Tools
A Polyclonal Antibody Directed Against the C-Terminus of HERG
WARF: P05253US
Inventors: Craig January, Qiuming Gong, Zhengfeng Zhou
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in a versatile polyclonal anti-HERG antibody.
Overview
HERG (human ether-a-go-go-related gene) encodes a potassium ion channel important for maintaining normal cardiac rhythm and cell growth.
The Invention
UW-Madison researchers have developed a versatile polyclonal anti-HERG antibody. This antibody was developed in 1997 using a fusion protein that included 181 amino acids from the C-terminus of HERG. It detects HERG 1a and 1b.
The antibody’s specificity has been tested by Western blot, immunohistochemical and immunoprecipitation assays, including histological characterization of native and expressed HERG channels. In validation tests, it outperformed commercially available antibodies for a range of uses.
The antibody’s specificity has been tested by Western blot, immunohistochemical and immunoprecipitation assays, including histological characterization of native and expressed HERG channels. In validation tests, it outperformed commercially available antibodies for a range of uses.
Applications
- Analysis of HERG channel proteins
Key Benefits
- More sensitive, selective and versatile than commercially available antibodies
- Reliable – has been used by academic labs worldwide for more than eight years
Additional Information
For More Information About the Inventors
Publications
- Zhou Z., Gong Q., Epstein M.L. and January C.T. 1998. HERG Channel Dysfunction in Human Long QT Syndrome: Intracellular Transport and Functional Defects. J. Biol. Chem. 273, 21061-21066.
Tech Fields
For current licensing status, please contact Jennifer Gottwald at [javascript protected email address] or 608-960-9854